Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Amortization of Deferred Charges of $12000.0 in Q1 2026, up 9.09% on a QoQ basis from $11000.0 in Q4 2025, and down 14.29% year-over-year from $14000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $12000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 14.29% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50000.0 (changed N/A YoY) and the FY2025 annual result came in at $52000.0, up 126.09% from the prior year.
- Amortization of Deferred Charges advanced to $12000.0 in Q1 2026, from $11000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $14000.0 in Q4 2024 and troughed at $11000.0 in Q4 2025.
- A 3-year average of $13000.0 and a median of $13500.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges slipped 21.43% — and 2026, when it retreated 14.29%.
- Tracing ACHV's Amortization of Deferred Charges over 3 years: stood at $14000.0 in 2024, then declined by 21.43% to $11000.0 in 2025, then gained by 9.09% to $12000.0 in 2026.
- Business Quant data shows ACHV's Amortization of Deferred Charges at $12000.0 in Q1 2026, $11000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |